FDA Investigates COVID Vaccine Pediatric Deaths
In a groundbreaking investigation, the FDA links COVID-19 vaccines to potential pediatric deaths, sparking intense debate and scrutiny.
Story Snapshot
The FDA is investigating reports...
AI Unveils Hidden Rare Diseases
A revolutionary AI system that can identify rare diseases from simple photographs is expanding its capabilities, potentially transforming how millions of patients receive diagnoses.
Story...
Bacon Without Pigs is Finally Here
Lab-grown bacon could soon hit American tables without a single pig being slaughtered, but this artificial meat push raises serious questions about food safety.
Story...
New Cure for Type 1 Diabetes Enters Trials
Groundbreaking stem cell therapy has achieved what many thought impossible—completely reversing Type 1 diabetes in human patients.
Story Highlights
Vertex Pharmaceuticals' zimislecel therapy enabled 10...
AI-Driven Brain Hacks: Revolutionary or Risky?
Imagine a world where your brain's cognitive performance can be optimized with AI-driven precision, transforming the way we approach brain stimulation therapies.
Story Overview
Personalized...
Bone Broth: The Timeless Health Elixir
That turkey carcass sitting in your refrigerator after the holiday feast isn't garbage—it's liquid gold waiting to transform into one of nature's most nutrient-dense...
BMI vs. Biomarkers: The Health Debate
Are you truly healthy, or is metabolic dysfunction hiding behind your scale's numbers?
Story Snapshot
Metabolic health can vary independently from body weight.
Specific biomarkers...
FDA Reverses Key Asbestos Safety Mandate
The Trump Administration just withdrew a rule that would have required cosmetics companies to test talc products for deadly asbestos contamination.
Story Overview
FDA withdrew...
Cannabis Cuts Alcohol Use by 27%?
A landmark clinical trial reveals that smoking cannabis reduces alcohol consumption by up to 27 percent.
Quick Take
Brown University researchers conducted the first randomized...
Medicare Slashes Ozempic Price by 71%
Medicare's latest negotiation slashes prices on Ozempic and Wegovy by a staggering 71%—a monumental shift in drug affordability.
Story Overview
Medicare successfully negotiated prices for...
